Holen Sie sich die Stockscreener-App
2.23
0.90%
0.02
Schlusskurs vom Vortag:
$2.21
Offen:
$2.25
24-Stunden-Volumen:
52,171
Relative Volume:
0.55
Marktkapitalisierung:
$14.25M
Einnahmen:
$14.58M
Nettoeinkommen (Verlust:
$-12.57M
KGV:
-0.3926
EPS:
-5.68
Netto-Cashflow:
$-13.07M
1W Leistung:
-7.85%
1M Leistung:
-13.23%
6M Leistung:
-46.52%
1J Leistung:
-3.04%
1-Tages-Spanne:
$2.16
$2.32
1-Wochen-Bereich:
$2.16
$2.47
52-Wochen-Spanne:
$1.97
$6.28
Vivos Therapeutics Inc Stock (VVOS) Company Profile
Firmenname
Vivos Therapeutics Inc
Sektor
Branche
Telefon
(866)908-4867
Adresse
7921 SOUTHPARK PLAZA,, LITTLETON
Vergleichen Sie VVOS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VVOS
Vivos Therapeutics Inc
|
2.23 | 14.25M | 14.58M | -12.57M | -13.07M | -5.68 |
|
ABT
Abbott Laboratories
|
133.58 | 232.41B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.09 | 155.73B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
383.89 | 146.23B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
87.44 | 106.37B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.52 | 45.88B | 5.54B | 4.18B | 623.10M | 7.00 |
Vivos Therapeutics Inc Aktie (VVOS) Neueste Nachrichten
vivos therapeutics appoints baker tilly as new auditor following merger - Investing.com Australia
vivos therapeutics appoints baker tilly as new auditor following merger By Investing.com - Investing.com South Africa
Vivos Therapeutics, Inc. (NASDAQ:VVOS) Sees Large Drop in Short Interest - Defense World
Sleep Apnea Oral Appliances MarketGlobal Forecast to - GlobeNewswire
Vivos Therapeutics (NASDAQ:VVOS) Cut to Sell at Wall Street Zen - Defense World
Vivos Therapeutics (NASDAQ:VVOS) Stock Rating Lowered by Alliance Global Partners - Defense World
Sector Update: Health Care - marketscreener.com
Vivos Issues $1.1 Million Convertible Promissory Note - marketscreener.com
Vivos Therapeutics Secures $1.1M Convertible Note - TipRanks
Vivos Therapeutics (NASDAQ:VVOS) Cut to “Hold” at Alliance Global Partners - Defense World
Vivos Therapeutics signals transformative growth with SCN acquisition and expects positive cash flow by end of 2025 - MSN
Vivos Therapeutics (VVOS) Downgraded Amidst Business Model Challenges | VVOS Stock News - GuruFocus
Vivos Therapeutics (VVOS) Downgraded Amidst Business Model Chall - GuruFocus
Why Vivos Therapeutics (VVOS) Stock Is Down 25% Today - MSN
Vivos Therapeutics’ Earnings Call: Strategic Shifts Amid Financial Challenges - TipRanks
Vivos Therapeutics Reports First Quarter 2025 Financial Results and Provides Operational Update - The Manila Times
Vivos Therapeutics Shifts Strategy Amid Financial Results - TipRanks
Earnings call transcript: Vivos Therapeutics reports Q1 2025 earnings, stock rises - Investing.com Nigeria
Vivos Therapeutics, Inc. (VVOS) Reports Q1 Loss, Lags Revenue Estimates - sharewise
Vivos Therapeutics Q1 2025 Financial Results - TradingView
Vivos Therapeutics Transforms Business Model with $9M Sleep Center Deal as Product Sales Rise - Stock Titan
Vivos to Report First Quarter Results - Dentistry Today
Vivos Therapeutics Schedules Release of First Quarter 2025 Financial Results and Conference Call - The Manila Times
Vivos Therapeutics, Inc. to Release First Quarter 2025 Financial Results on May 15, 2025 - Nasdaq
Sleep Apnea Tech Leader Vivos Therapeutics Reports Q1 2025 Earnings TomorrowKey Details Here - Stock Titan
Vivos Therapeutics (VVOS) to Release Quarterly Earnings on Tuesday - Defense World
Vivos Therapeutics Inc expected to post a loss of 40 cents a shareEarnings Preview - TradingView
Vivos Therapeutics, Inc. (VVOS) May Report Negative Earnings: Know the Trend Ahead of Q1 Release - MSN
Geode Capital Management LLC Grows Stock Holdings in Vivos Therapeutics, Inc. (NASDAQ:VVOS) - Defense World
Veterinary Cancer Breakthrough: Vivos Reports 150% Growth, Expands Novel Treatment to Horses - Stock Titan
In brief: Revelstoke recaps AOM, Vivos to make buy, state legislation makes tracks - HME News
Healthcare Stocks Take A Hit Despite Abbott's Earnings Beat - Finimize
Vivos Therapeutics to acquire operating assets of The Sleep Center of Nevada - MSN
Vivos Therapeutics to Acquire The Sleep Center of Nevada - marketscreener.com
Vivos Opens New Sleep Center - Baystreet.ca
Vivos Therapeutics announces agreement to acquire operating assets of SCN - TipRanks
Vivos To Acquire Operating Assets Of The Sleep Center Of Nevada - Nasdaq
Vivos Therapeutics Signs Definitive Agreement To Acquire Largest Sleep Center Operator In Nevada - marketscreener.com
Vivos Therapeutics Signs Definitive Agreement to Acquire Largest Sleep Center Operator in Nevada - The Manila Times
Major Healthcare Expansion: Vivos Takes Over Nevada Sleep Giant Serving 3,000 Monthly Patients - Stock Titan
InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Releases Report on Q2 2024 Financial Results, Operational Update - MSN
Commonwealth Equity Services LLC Buys 5,000 Shares of Vivos Therapeutics, Inc. (NASDAQ:VVOS) - Defense World
In Vivo’s 2025 Rising Leaders - insights.citeline.com
Positive Sentiment Still Eludes Vivos Therapeutics, Inc. (NASDAQ:VVOS) Following 26% Share Price Slump - simplywall.st
Groundbreaking Collaboration: Vivos Therapeutics and Cellev8 Nutrition Join Forces to Address Sleep Apnea and Oxidative Stress - ACCESS Newswire
Vivos Therapeutics Inc (VVOS) Q4 2024 Earnings Call Highlights: Strategic Shifts Propel Revenue ... By GuruFocus - Investing.com Canada
Vivos Therapeutics, Inc. (VVOS) Reports Q4 Loss, Lags Revenue Estimates - MSN
Finanzdaten der Vivos Therapeutics Inc-Aktie (VVOS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.56%
1.70%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):